Geron Announces Conference Call on April 10 at 8:00 A.M. Eastern Time
April 09 2017 - 8:00AM
Geron Corporation (Nasdaq:GERN) will host a conference call on
April 10, 2017, at 8:00 a.m. Eastern Time to provide an update on
the ongoing imetelstat Phase 2/3 trial in myelodysplastic syndromes
and the Phase 2 trial in myelofibrosis.
Participants can access the conference call live via telephone
by dialing 877-303-9139 (U.S.); 760-536-5195 (international). The
conference ID number is 6116409. If accessing the conference call
by telephone, please dial in at least 10 minutes early to minimize
any delay in joining the call. A live audio-only webcast will also
be available through the company’s website at www.geron.com in
the Investors section under Events and at
http://edge.media-server.com/m/p/w5mtfw9k. The audio webcast of the
conference call will be available for replay approximately one hour
following the live broadcast through May 11, 2017.
About Geron
Geron is a clinical stage biopharmaceutical company focused on
the collaborative development of a first-in-class telomerase
inhibitor, imetelstat, in hematologic myeloid malignancies. For
more information about Geron, visit www.geron.com.
CONTACT:
Anna Krassowska, Ph.D.
Investor and Media Relations
650-473-7765
investor@geron.com
media@geron.com
Geron (NASDAQ:GERN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Geron (NASDAQ:GERN)
Historical Stock Chart
From Apr 2023 to Apr 2024